Skip to main content

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Bicara Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
84
+15 vs. Q3 2024
Shares held
46.7M
+10.3M (+28.3%) vs. Q3 2024
Total value
$813.6M
−$114.0M (−12.3%) vs. Q3 2024
New holders
39
23 more added
Sold out
24
7 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 84 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 69 institutionsQ4 2024: 84 institutionsQ1 2025: 93 institutionsQ2 2025: 106 institutionsQ3 2025: 114 institutionsQ4 2025: 140 institutionsQ1 2026: 145 institutionsQ2 2026: 171 institutions
Value heldQ4 2024: $813.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $927.6MQ4 2024: $813.6MQ1 2025: $633.9MQ2 2025: $475.3MQ3 2025: $792.5MQ4 2025: $960.7MQ1 2026: $1.35BQ2 2026: $2.07B
Institutions holding BCAX and their total value by quarter
QuarterHoldersValue
Q2 2026171$2.07B
Q1 2026145$1.35B
Q4 2025140$960.7M
Q3 2025114$792.5M
Q2 2025106$475.3M
Q1 202593$633.9M
Q4 202484$813.6M
Q3 202469$927.6M
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Bicara Therapeutics Inc.; share changes are against Q3 2024.

Institutions holding BCAX in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
New York State Common Retirement Fund0$00.00%−17,227−100.0%Sold out
Legato Capital Management LLC0$00.00%−14,179−100.0%Sold out
Teachers Retirement System of the State of Kentucky0$00.00%−14,039−100.0%Sold out
Greenland Capital Management LP0$00.00%−12,296−100.0%Sold out
Jane Street Group, LLC0$00.00%−12,151−100.0%Sold out
Davidson Kempner Capital Management LP0$00.00%−10,000−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−10,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−9,000−100.0%Sold out